Virus News and Research

Latest Virus News and Research

Detection of emerging SARS-CoV-2 variant in New York

Researchers at the California Institute of Technology in Pasadena have developed a software tool called "Variant Database" that has detected an emerging lineage of severe acute respiratory coronavirus 2 (SARS-CoV-2) isolates in New York.

16 Feb 2021

Stability and pathogenicity of MERS coronavirus varies across different viral strains

An international team of researchers has conducted a study suggesting that individual variation across different strains of betacoronaviruses can alter their stability and pathogenicity profiles.

16 Feb 2021

Asthma may influence the evolution of influenza virus, study shows

A subtype of asthma in adults may cause higher susceptibility to influenza and could result in dangerous flu mutations.

16 Feb 2021

A pangolin coronavirus spike glycoprotein sheds light on SARS-CoV-2’s evolution

As the exact zoonotic origin of SARS-CoV-2 remains unresolved, scientists at the Francis Crick Institute in London, UK, explored the structure and binding properties of a Pangolin coronavirus spike glycoprotein to see if it could shed light on the evolution of SARS-CoV-2.

16 Feb 2021

UV light can be used to disinfect SARS-CoV-2 contaminated surfaces, says study

Using different UV exposure times and dosages, researchers showed that surfaces like glass, plastic, stainless steel, and N95 respirator material could be quickly and easily disinfected.

16 Feb 2021

Vaccines go mobile to keep seniors from slipping through the cracks

A mobile "strike team" is bringing vaccines to some of Northern California’s most vulnerable residents along with a message: This is how you avoid dying from covid-19.

16 Feb 2021

Anti-immigrant vitriol complicates vaccine rollout in Southern states

In eastern Tennessee, doctors have seen firsthand how a hard-line immigration policy can affect the health and well-being of a community.

16 Feb 2021

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

Researchers in France report impaired neutralization of two new SARS-CoV-2 variants by antibodies induced by vaccination or natural infection.

16 Feb 2021

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

A new preprint research paper posted to the bioRxiv server provides a greater understanding of the aspect of humoral immunity against the virus – the plasma cells that pour out a flood of specific antibodies targeting various epitopes on the pathogen.

16 Feb 2021

Mink-derived SARS-CoV-2 mutations reduce antibody effectiveness

A new preprint research paper posted to the bioRxiv* server shows that these mutations disrupt inhibition by neutralizing antibodies, both natural and therapeutic.

16 Feb 2021

CDC says vaccinated individuals can skip COVID quarantines

The coronavirus disease (COVID-19) pandemic's global case toll has surpassed 109 million globally. Of these infections, 2.4 million people have already succumbed to the disease. As the pandemic continues to spread, many countries have rolled out vaccinations.

15 Feb 2021

What makes some people COVID superspreaders?

The study, published in the journal Proceedings of the National Academy of Sciences, showed that older, obese people who have an acute COVID-19 infection release more aerosols, increasing viral transmission potential.

15 Feb 2021

Nanoparticle COVID-19 vaccine stimulates robust and long lasting immunity in primates

In the study, published on the preprint server bioRxiv, the team evaluated the ability of AS03, CpG 1018 formulated in Alum, the TLR-7 agonist adsorbed to Alum (AS37), the squalene-in-water emulsion (O/W), and Alum to boost protective immunity against SARS-CoV-2.

15 Feb 2021

Research shows rapid global spread of Southern California COVID-19 strain

A new strain of the coronavirus in Southern California, first reported last month by Cedars-Sinai, is rapidly spreading across the country and around the world as travelers apparently carry the virus with them to a growing list of global destinations, according to new research published today in the peer-reviewed Journal of the American Medical Association.

15 Feb 2021

How SARS-CoV-2 enters the central nervous system

The central nervous system (CNS) is highly protected in the human body. Yet, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) invades the CNS, causing profound clinical complications. How is the CNS involved in a respiratory virus infection?

15 Feb 2021

Pitt scientists develop fast, efficient technique for discovering tiny antibody fragments

By capitalizing on a convergence of chemical, biological and artificial intelligence advances, University of Pittsburgh School of Medicine scientists have developed an unusually fast and efficient method for discovering tiny antibody fragments with big potential for development into therapeutics against deadly diseases.

15 Feb 2021

Researchers report a new SARS-CoV-2 variant of concern in Uganda

An interdisciplinary research team from Uganda and the UK report the emergence and spread of a new SARS-CoV-2 variant of the A lineage with multiple protein changes throughout the viral genome.

15 Feb 2021

Researchers observe rapid increase of SARS-CoV-2 antibodies in plasma over pandemic's course

Researchers found that neutralizing antibodies against SARS-CoV-2 can increase over time. They observed that samples taken from convalescent plasma in September 2020 would likely have high enough values by July 2021 to protect immunodeficient patients who receive intravenous immunoglobulins as part of their treatment.

15 Feb 2021

Scientists discover new immunotherapy target for malignant brain tumors

Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted the ground-breaking cancer treatment based on harnessing the body's immune system.

15 Feb 2021

SARS-CoV-2 South Africa and Brazil variants show resistance to therapeutic antibodies

Scientists from Germany have determined the efficacy of currently used therapeutics in treating newer variants of SARS-CoV-2, including the UK, South Africa, and Brazil variants. Their findings reveal that both B.1.351 and B.1.1.248 variants are able to escape humoral immune responses induced by therapeutic antibodies, vaccinations, or natural SARS-CoV-2 infection.

15 Feb 2021

Virus News and Research

Latest Virus News and Research

Detection of emerging SARS-CoV-2 variant in New York

Stability and pathogenicity of MERS coronavirus varies across different viral strains

Asthma may influence the evolution of influenza virus, study shows

A pangolin coronavirus spike glycoprotein sheds light on SARS-CoV-2’s evolution

UV light can be used to disinfect SARS-CoV-2 contaminated surfaces, says study

Vaccines go mobile to keep seniors from slipping through the cracks

Anti-immigrant vitriol complicates vaccine rollout in Southern states

British and South African SARS-CoV-2 variants show some resistance to neutralizing antibodies

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

Mink-derived SARS-CoV-2 mutations reduce antibody effectiveness

CDC says vaccinated individuals can skip COVID quarantines

What makes some people COVID superspreaders?

Nanoparticle COVID-19 vaccine stimulates robust and long lasting immunity in primates

Research shows rapid global spread of Southern California COVID-19 strain

How SARS-CoV-2 enters the central nervous system

Pitt scientists develop fast, efficient technique for discovering tiny antibody fragments

Researchers report a new SARS-CoV-2 variant of concern in Uganda

Researchers observe rapid increase of SARS-CoV-2 antibodies in plasma over pandemic's course

Scientists discover new immunotherapy target for malignant brain tumors

SARS-CoV-2 South Africa and Brazil variants show resistance to therapeutic antibodies

A new way of characterising biomolecules eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in